TC
LGND icon

TownSquare Capital’s Ligand Pharmaceuticals LGND Stock Holding History

TownSquare Capital’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$206K Buy
+653
New +$154K 0.04% 269
2025
Q3 		– Sell
-4,259
Closed -$484K – 509
2025
Q2 		$484K Sell
4,259
-32,515
-88% -$3.48M 0.05% 349
2025
Q1 		$3.87M Buy
36,774
+2,235
+6% +$253K 0.04% 385
2024
Q4 		$3.7M Buy
34,539
+4,726
+16% +$534K 0.04% 390
2024
Q3 		$2.98M Buy
29,813
+3,140
+12% +$316K 0.04% 431
2024
Q2 		$2.25M Buy
+26,673
New +$2.12M 0.03% 478
2022
Q2 		– Sell
-6,891
Closed -$484K – 752
2022
Q1 		$484K Buy
6,891
+1,109
+19% +$80.5K 0.01% 501
2021
Q4 		$557K Buy
5,782
+3,193
+123% +$295K 0.01% 460
2021
Q3 		$225K Buy
+2,589
New +$200K 0.01% 643

Other funds holding LGND

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

TownSquare Capital's LGND Position: Q2 2026 in Review

TownSquare Capital opened a new position in Ligand Pharmaceuticals (LGND) in Q2 2026: 653 shares worth $206K. The stake represents 0.04% of the portfolio and ranks #269 among its holdings. This is a return to the name: TownSquare Capital previously reported a position in LGND as recently as Q2 2025.

TownSquare Capital first reported a position in LGND in Q3 2021 and has held it in 9 quarters since. The position peaked at $3.87M in Q1 2025. 417 funds tracked by Wall St. Rank hold LGND as of Q2 2026.

  • TownSquare Capital held 653 shares of Ligand Pharmaceuticals worth $206K as of Q2 2026.
  • Ligand Pharmaceuticals was a new TownSquare Capital position in Q2 2026.
  • Ligand Pharmaceuticals made up 0.04% of TownSquare Capital's portfolio in Q2 2026, its #269 holding.
  • TownSquare Capital first reported a position in Ligand Pharmaceuticals in Q3 2021 and has held it in 9 quarters since.
  • TownSquare Capital's Ligand Pharmaceuticals position peaked at $3.87M in Q1 2025.
  • 417 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2026.

Based on TownSquare Capital's 13F filing for Q2 2026, filed 14 Aug 2026.